Beckman Coulter Immage Immunochemistry System Low Concentration Immunoglobulin A (Igalc) Reagent, Beckman Coulter Cerebr
Method, Nephelometric, Immunoglobulins (G, A, M). 510(k) K993549, from Beckman Coulter, Inc. (Brea, CA). Product code CFN, class 2.
As of Nov 19, 2026, K993549 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Feb 1, 2000 after 105 days, with no recalls tied to it in FDA's recall database.
- Review time: 105 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The IMMAGE® Immunochemistry System Low Concentration Immunoglobulin A (IGALC) Reagent, when used in conjunction with Beckman Coulter's IMMAGE® Immunochemistry Systems and Cerebrospinal Fluid Protein Calibrator, is intended for the quantitative determination of human immunoglobulin A in serum and cerebrospinal fluid by rate nephelometry.
- Immage Immunochemistry System Immunoglobulin G (Igg), A (Iga) and M (Igm)K963868 · Beckman Instruments, Inc. · Feb 10, 1997
- N Latex IgaK952309 · Behring Diagnostics, Inc. · Jun 20, 1995
- Optilite IgA CSF KitK183151 · The Binding Site Group , Ltd. · Jan 23, 2019
- Immage Systems Low Concentration Immunoglobulin A ReagentK060130 · Beckman Coulter, Inc. · Feb 13, 2006
- N Latex IgaK024038 · Dade Behring, Inc. · Feb 13, 2003
- N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)K233663 · Siemens Healthcare Diagnostics Products GmbH · Dec 13, 2023
- Immunoglobulin G (IgG)K221114 · Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. · Aug 2, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 19, 1999
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5510
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files